Who
Jill G. Mcconnell
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Fortrea Holdings.
In numbers
- Trades disclosed
- 91
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $422K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jun 2023
- Last trade
- 2 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $75K4,866 at $15.49 | filing |
| 2 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $75K4,866 at $15.49 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 16 Mar 2026filed 17 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $17K1,804 at $9.22 | filing |
| 16 Mar 2026filed 17 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $17K1,804 at $9.22 | filing |
| 13 Mar 2026filed 17 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —4,284 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,284 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,284 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —4,284 at $0.00 | filing |
| 10 Mar 2026filed 11 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $23K2,530 at $8.93 | filing |
| 10 Mar 2026filed 11 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $23K2,531 at $9.21 | filing |
| 10 Mar 2026filed 11 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $23K2,530 at $8.93 | filing |
| 10 Mar 2026filed 11 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $23K2,531 at $9.21 | filing |
| 9 Mar 2026filed 11 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —15,283 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —15,283 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —15,283 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —15,283 at $0.00 | filing |
News
Critical Review: Champions Oncology (NASDAQ:CSBR) and Fortrea (NASDAQ:FTRE)FTRE · dailypolitical.com · 18 Oct 2026Reviewing MindWalk (NASDAQ:HYFT) & Fortrea (NASDAQ:FTRE)FTRE · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Jill G. Mcconnell; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.